Brain cancer (BC) can be difficult to treat if the patient or survivor thinks only about conventional (FDA approved) therapies. While surgical tumor reduction is almost always the first and best method to “debulk” a cancer, sometimes it’s impossible to cut out the tumor. The articles below cite vaccines for BCs- vaccines that function as a primary therapy or as an integrative therapy.
The challenge of the BC patient is to learn everything there is to know about brain cancer in the days and weeks following your diagnosis. A tall order to put it mildly.
I can help. I am both a long-term cancer survivor and cancer coach. Experience and research has taught me that patients diagnosed with incurable cancers must think outside the box when it comes to treating their cancer. Conventional, evidence-based non-conventional, integrative, complementary- patients must use every possible tool in the cancer therapy tool box.
For more information about all forms of evidence-based BC therapies, scroll down the page, post a question or comment and I will reply ASAP.
“An experimental immune-based therapy more than doubled median survival of patients diagnosed with the most aggressive malignant brain tumor…Median survival in a Phase I clinical trial at Cedars-Sinai’s Johnnie L. Cochran, Jr. Brain Tumor Center was 38.4 months, significantly longer than the typical 14.6-month survival of patients with newly diagnosed glioblastoma receiving standard therapy alone, which includes radiation and chemotherapy….”
“There are more than 120 different types of brain tumors, afflicting nearly 700,000 people in the U.S. and killing nearly 17,000 every year, according to the American Brain Tumor Association. The Biden family didn’t disclose Beau’s type of brain cancer, but some have speculated it was likely a glioblastoma, a particularly aggressive type of brain tumor that is among the most common adult brain cancers…
Right now, the standard treatment for glioblastoma is a combination of surgery, radiation and chemotherapy. There are few options when those fail, but Holland is cautiously optimistic for the future. He believes with an as-yet-to-be-determined combination of immunotherapy and precision medicine, brain cancer researchers may finally make some headway against this long intractable problem…”